ConductScience.org, home

Paper36200045

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy.

Xiao C and 11 others. Front Cell Dev Biol, 2022. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy. Papers, record 36200045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36200045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy.
PubMed
Journal
Front Cell Dev Biol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
2.59
iCite
Revised in PubMed
2022-10-07
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xiao CChu
2Tian HHe
3Zheng YYujia
4Yang ZZhenlin
5Li SShuofeng
6Fan TTao
7Xu JJiachen
8Bai GGuangyu
9Liu JJingjing
10Deng ZZiqin
11Li CChunxiang
12He JJie

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References146

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135856800A Nanounit Strategy Disrupts Energy Metabolism and Alleviates Immunosuppression for Cancer Therapy.Nano Lett2022https://conductscience.org/library/papers/35856800PubMed
222988108Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22988108PubMed
335131452Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanoma.Ann Oncol2022https://conductscience.org/library/papers/35131452PubMed
417255361Inhibitory effect of tumor cell-derived lactic acid on human T cells.Blood2007https://conductscience.org/library/papers/17255361PubMed
536007522Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα.Cell Metab2022https://conductscience.org/library/papers/36007522PubMed
626321679Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.Cell2015https://conductscience.org/library/papers/26321679PubMed
735869449The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors.Cell Mol Biol Lett2022https://conductscience.org/library/papers/35869449PubMed
834887262Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.J Immunother Cancer2021https://conductscience.org/library/papers/34887262PubMed
918490716Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway.J Immunol2008https://conductscience.org/library/papers/18490716PubMed
1034163475Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes.Front Immunol2021https://conductscience.org/library/papers/34163475PubMed
1126755257The Effects of Severe Hypoxia on Glycolytic Flux and Enzyme Activity in a Model of Solid Tumors.J Cell Biochem2016https://conductscience.org/library/papers/26755257PubMed
1225533673PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.Nat Rev Cancer2015https://conductscience.org/library/papers/25533673PubMed
1330266938Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.Sci Rep2018https://conductscience.org/library/papers/30266938PubMed
1435489446Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity.Cancer Lett2022https://conductscience.org/library/papers/35489446PubMed
1534912709GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma.Front Oncol2021https://conductscience.org/library/papers/34912709PubMed
1633588426CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours.Nature2021https://conductscience.org/library/papers/33588426PubMed
1735945217MYC sensitises cells to apoptosis by driving energetic demand.Nat Commun2022https://conductscience.org/library/papers/35945217PubMed
1832917658Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer.Cancer Immunol Res2020https://conductscience.org/library/papers/32917658PubMed
1933715980Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice.Int Immunopharmacol2021https://conductscience.org/library/papers/33715980PubMed
2030988188Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30988188PubMed

See all 146 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42938904Cancer Cell Metabolic Reprogramming: Dietary, Pharmacological Strategies and Clinical Perspectives.Cancers (Basel)2026https://conductscience.org/library/papers/42938904PubMed
42755018PD-L1 in Ovarian Cancer: Immune Evasion, Tumor-Intrinsic Signaling, and Chemoresistance.Cancer Med2026https://conductscience.org/library/papers/42755018PubMed
42653493Lactate as a Master Regulator of Immune Suppression: From Metabolic Waste to Epigenetic Checkpoint in Colorectal Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/42653493PubMed
42291355The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42291355PubMed
42045432KDM8/c-Myc axis-mediated glucose metabolism reprogramming promotes the progression of ovarian cancer.Sci Rep2026https://conductscience.org/library/papers/42045432PubMed
42032347Mechanism exploration of di(2-ethylhexyl) phthalate (DEHP)-induced hepatocellular carcinoma via network toxicology and molecular docking analysis.Discov Oncol2026https://conductscience.org/library/papers/42032347PubMed
419727212,3-Bisphosphoglycerate Mutase (BPGM), a Metabolic Player Shaping Stress-Adaptive Transcriptional States in Clear Cell Renal Cell Carcinoma.Cells2026https://conductscience.org/library/papers/41972721PubMed
41670818Genomic alterations and their correlation with metabolic-related genes in lung cancer.Clin Transl Oncol2026https://conductscience.org/library/papers/41670818PubMed
41639833The mechanism by which KAT2A increases the stability of CDC25A through acetylation to regulate glycolysis and mediate lung adenocarcinoma immune escape.Respir Res2026https://conductscience.org/library/papers/41639833PubMed
41053006Lactate-mediated histone lactylation promotes melanoma angiogenesis via IL-33/ST2 axis.Cell Death Dis2025https://conductscience.org/library/papers/41053006PubMed
40927315SLC16A3 (MCT4) expression in tumor immunity and Metabolism: Insights from pan-cancer analysis.Biochem Biophys Rep2025https://conductscience.org/library/papers/40927315PubMed
40175681Role of metabolic transformation in cancer immunotherapy resistance: molecular mechanisms and therapeutic implications.Discov Oncol2025https://conductscience.org/library/papers/40175681PubMed
40051496Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.Cancer Drug Resist2025https://conductscience.org/library/papers/40051496PubMed
39902867Leptin decreases Th17/Treg ratio to facilitate neuroblastoma via inhibiting long-chain fatty acid catabolism in tumor cells.Oncoimmunology2025https://conductscience.org/library/papers/39902867PubMed
39405607Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.Transl Oncol2024https://conductscience.org/library/papers/39405607PubMed
39167430Comprehensive multi-omics analysis reveals a combination of lncRNAs that synergistically regulate glycolysis and immunotherapeutic effects in renal clear cell carcinoma.Aging (Albany NY)2024https://conductscience.org/library/papers/39167430PubMed
39158178A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/39158178PubMed
38893213Triple Negative Breast Cancer: Molecular Subtype-Specific Immune Landscapes with Therapeutic Implications.Cancers (Basel)2024https://conductscience.org/library/papers/38893213PubMed
38653823Integrating tumor and healthy epithelium in a micro-physiology multi-compartment approach to study renal cell carcinoma pathophysiology.Sci Rep2024https://conductscience.org/library/papers/38653823PubMed
38481985Metabolic reprogramming and signalling cross-talks in tumour-immune interaction: a system-level exploration.R Soc Open Sci2024https://conductscience.org/library/papers/38481985PubMed

See all 27 cited byDownload CSV of cited by

Genes57

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACACA31PubTator's text mininghttps://conductscience.org/library/genes/31NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ATP2A3489PubTator's text mininghttps://conductscience.org/library/genes/489NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD40LG959PubTator's text mininghttps://conductscience.org/library/genes/959NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXADRP1653108PubTator's text mininghttps://conductscience.org/library/genes/653108NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GPI2821PubTator's text mininghttps://conductscience.org/library/genes/2821NCBI Gene
GZMB3002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
HCAR127198PubTator's text mininghttps://conductscience.org/library/genes/27198NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene

See all 57 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36200045

GET https://conductscience.org/api/papers/v1/36200045/references?page=2